Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe M O'Sullivan

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
Journal of Medical Imaging and Radiation Sciences|August 21, 2019
Where Do We See Alpha Emitters in Clinical Practice? A Radiation Oncology PerspectiveJoe M O'Sullivan
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 10, 2005
Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantationJonathan McAleese, Joe M O'Sullivan
Nature Reviews. Cancer|April 21, 2009
Radiation-induced bystander signalling in cancer therapyKevin M Prise, Joe M O'Sullivan
The Cochrane Database of Systematic Reviews|February 27, 2013
Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapyBrenda Nugent, Sian Lewis, Joe M O'Sullivan
International Journal of Clinical Practice|July 13, 2020
Use of bisphosphonates and other bone supportive agents in the management of prostate cancer-A UK perspectiveHeather Payne, Amit Bahl, Joe M O'Sullivan
The Cochrane Database of Systematic Reviews|March 19, 2010
Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapyBrenda Nugent, Sian Lewis, Joe M O'Sullivan
Current Opinion in Supportive and Palliative Care|June 20, 2012
Use of radionuclides in metastatic prostate cancer: pain relief and beyondSalil Vengalil, Joe M O'Sullivan, Christopher C Parker
Future Oncology (London, England)|March 21, 2023
Integrating radium-223 therapy into the management of metastatic prostate cancer care: a plain language summaryJoe M O'Sullivan, Elliot Abramowitz, Len Sierra-Scacalossi
Cancer Journal (Sudbury, Mass.)|January 23, 2013
Bone-targeting radiopharmaceuticals including radium-223Darren Brady, Chris C Parker, Joe M O'Sullivan
Frontiers in Oncology|August 23, 2013
What is the Role of the Bystander Response in Radionuclide Therapies?Darren Brady, Joe M O'Sullivan, Kevin M Prise
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
Journal of Medical Imaging and Radiation Sciences|August 21, 2019
Where Do We See Alpha Emitters in Clinical Practice? A Radiation Oncology PerspectiveJoe M O'Sullivan
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 10, 2005
Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantationJonathan McAleese, Joe M O'Sullivan
Nature Reviews. Cancer|April 21, 2009
Radiation-induced bystander signalling in cancer therapyKevin M Prise, Joe M O'Sullivan
The Cochrane Database of Systematic Reviews|February 27, 2013
Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapyBrenda Nugent, Sian Lewis, Joe M O'Sullivan
International Journal of Clinical Practice|July 13, 2020
Use of bisphosphonates and other bone supportive agents in the management of prostate cancer-A UK perspectiveHeather Payne, Amit Bahl, Joe M O'Sullivan
The Cochrane Database of Systematic Reviews|March 19, 2010
Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapyBrenda Nugent, Sian Lewis, Joe M O'Sullivan
Current Opinion in Supportive and Palliative Care|June 20, 2012
Use of radionuclides in metastatic prostate cancer: pain relief and beyondSalil Vengalil, Joe M O'Sullivan, Christopher C Parker
Future Oncology (London, England)|March 21, 2023
Integrating radium-223 therapy into the management of metastatic prostate cancer care: a plain language summaryJoe M O'Sullivan, Elliot Abramowitz, Len Sierra-Scacalossi
Cancer Journal (Sudbury, Mass.)|January 23, 2013
Bone-targeting radiopharmaceuticals including radium-223Darren Brady, Chris C Parker, Joe M O'Sullivan
Frontiers in Oncology|August 23, 2013
What is the Role of the Bystander Response in Radionuclide Therapies?Darren Brady, Joe M O'Sullivan, Kevin M Prise
Pageof 15